雜志介紹

Purinergic Signalling雜志介紹

《Purinergic Signalling》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱嘌呤能信號(hào)，本刊主要出版、報(bào)道醫(yī)學(xué)-NEUROSCIENCES領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3，最新CiteScore 指數(shù)為6.6。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Purinergic signaling: a potential therapeutic target for depression and chronic pain

  Author: Zou, Yuting; Yang, Runan; Li, Lin; Xu, Xiumei; Liang, Shangdong

• Purinergic ATP triggers moxibustion-induced local anti-nociceptive effect on inflammatory pain model

  Author: Yin, Hai-Yan; Fan, Ya-Peng; Liu, Juan; Li, Dao-Tong; Guo, Jing; Yu, Shu-Guang

• In silico identification of A1 agonists and A2a inhibitors in pain based on molecular docking strategies and dynamics simulations

  Author: Xu, Guangya; Zhang, Shutao; Zheng, Lulu; Hu, Zhongjiao; Cheng, Lijia; Chen, Lvlin; Li, Jun; Shi, Zheng

• Inhibition of phosphorylated calcium/calmodulin-dependent protein kinase II alpha relieves streptozotocin-induced diabetic neuropathic pain through regulation of P2X3 receptor in dorsal root ganglia

  Author: He, Xiao-fen; Kang, Yu-rong; Fei, Xue-yu; Chen, Lu-hang; Li, Xiang; Ma, Yi-qi; Hu, Qun-qi; Qu, Si-ying; Wang, Han-zhi; Shao, Xiao-mei; Liu, Bo-yi; Yi-Liang; Du, Jun-ying; Fang, Jian-qiao; Jiang, Yong-liang

英文介紹

Purinergic Signalling雜志英文介紹

Nucleotides and nucleosides are primitive biological molecules that were utilized early in evolution both as intracellular energy sources and as extracellular signalling molecules. ATP was first identified as a neurotransmitter and later as a co-transmitter with all the established neurotransmitters in both peripheral and central nervous systems. Four subtypes of P1 (adenosine) receptors, 7 subtypes of P2X ion channel receptors and 8 subtypes of P2Y G protein-coupled receptors have currently been identified. Since P2 receptors were first cloned in the early 1990’s, there is clear evidence for the widespread distribution of both P1 and P2 receptor subtypes in neuronal and non-neuronal cells, including glial, immune, bone, muscle, endothelial, epithelial and endocrine cells.